Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Administered as a once-weekly subcutaneous injection, semaglutide slows gastric emptying, increases feelings of fullness, and reduces hunger signals
This needle-free option uses advanced absorption technology to deliver results comparable to injectable treatments, making it an ideal choice for patients who prefer to avoid shots or need a more travel-friendly routine
Available in 5mg lyophilized vials
Average appetite score for the week: Compare to previous weeks
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a class of medications originally developed for type 2 diabetes and, more recently, obesity treatment
US$ 26.79
US$ 21.03
US$ 27.95
